ANDA 203917, held by Rising. Acetazolamide.
As of Nov 13, 2026, ANDA 203917 (Acetazolamide), held by Rising, was first approved by FDA on Jun 18, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 18, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetazolamide500MG ยท capsule, extended release;oral | Acetazolamide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
